DIMERCAPROL Solution for injection Ref.[9520] Active ingredients: Dimercaprol

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2014  Publisher: Amdipharm UK Limited, Capital House, 85 King William Street, London EC4N 7BL, United Kingdom

Therapeutic indications

Dimercaprol Injection is indicated in adults and children for the treatment of acute poisoning by certain heavy metals, arsenic, mercury, gold, bismuth, antimony and possibly thallium. Although dimercaprol has not been successful in the treatment of lead poisoning when used alone, there is evidence that used in conjunction with sodium calcium edetate, it can be used successfully in the treatment of lead poisoning, particularly in children.

Posology and method of administration

Posology

Adults

400-800 mg, in divided doses, on the first day.
200-400 mg, in divided doses, on the second and third days.
100-200 mg, in divided doses, on the subsequent days.

Within the above dose range, individual dosage should be calculated on a bodyweight basis and will depend upon the severity of symptoms and the causative agent. As a general guide, single doses should not exceed 3 mg per kg bodyweight. However, in severe acute poisoning, single doses up to 5 mg per kg bodyweight may be required initially.

Paediatric population

Dimercaprol Injection is well tolerated by children and the dosage should be calculated on the basis of bodyweight, using the same unit dose per kg of bodyweight as for an adult under similar clinical circumstances.

Elderly

There are no specific data on the use of dimercaprol in the elderly but since it is eliminated via the kidney, it should be used with caution in this age group.

Method of administration

For intramuscular injection.

Overdose

Symptoms

Symptoms of over dosage include malaise, nausea, vomiting, lacrimation and salivation, burning sensation of lips, mouth, throat and eyes with headache. A sense of constriction of the throat and chest. Increased blood pressure maximal after 15-20 minutes. Transient effects lasting about four hours.

Management

Treatment consists of the subcutaneous administration of diphenhydramine 50 mg or ephedrine 30 mg or ephedrine in a dosage of 30-60 mg orally if time permits.

Shelf life

Shelf life: 3 years.

Special precautions for storage

Store at 2ยบ-25ยฐC. Protect from light.

Nature and contents of container

A 2 ml clear neutral glass ampoule with ceramic breakring. Pack sizes of 1 ampoule packed in a cardboard carton, or 10 ampoules packed in a polystyrene pack within a cardboard sleeve.

Special precautions for disposal and other handling

Special precautions for disposal: react with weak aqueous solution (up to 15% of calcium hypochlorite). Leave for 24 hours. Neutralise and discharge to drain with copious quantities of water.

ยฉ All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.